RE: RNS out12 Apr 2021 19:49
Amran - I'm not sure that CBX over-hyped it. I would point the finger at a number of posters here that got caught up in the excitement, bought on the initial spike and spent weeks spouting misinformation in order to get out with their shirts on their backs.
The company could do well but it will be entering a playing field populated by more and more suppliers. The reality is that they don't have the celebrity endorsement of DB (despite what many constantly state as fact) and don't really have anything unique at this moment (there are plenty of synthetic CBD suppliers, companies with special serum products and a number of companies targeting the sports market). At this point in time we don't know what the branding will be and have no idea of where it will be sold.
Jacksdad states that first estimates are for 250,000 customers (which he says is conservative) - where are those estimates from and what are they based on? That sounds very rampy to me and when statements like that are made they need to be backed up otherwise they carry no weight.
The danger is that people's expectations at the moment are too great for where the company is. Calls for RNS releases and revenues show a lack of understanding as the company does not yet have products. This is an early stage and patience should be rewarded - those hoping to make a quick buck now have missed the boat if they didn't get their IPO allocation. The old adage of sell in May and go away could be very apt here as it's unlikely that there will any major rises or falls in the SP for a while yet.